PFBT
RCKT icon

Parkside Financial Bank & Trust’s Rocket Pharmaceuticals RCKT Stock Holding History

Parkside Financial Bank & Trust’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$465 Buy
+130
New +$517 ﹤0.01% 2576
2025
Q2 		– Sell
-110
Closed -$731 – 2951
2025
Q1 		$731 Buy
+110
New +$1.09K ﹤0.01% 2206

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Parkside Financial Bank & Trust's RCKT Position: Q1 2026 in Review

Parkside Financial Bank & Trust opened a new position in Rocket Pharmaceuticals (RCKT) in Q1 2026: 130 shares worth $465. The stake represents ﹤0.01% of the portfolio and ranks #2576 among its holdings. This is a return to the name: Parkside Financial Bank & Trust previously reported a position in RCKT as recently as Q1 2025.

Parkside Financial Bank & Trust first reported a position in RCKT in Q1 2025 and has held it in 2 quarters since. The position peaked at $731 in Q1 2025. 199 funds tracked by Wall St. Rank hold RCKT as of Q1 2026.

  • Parkside Financial Bank & Trust held 130 shares of Rocket Pharmaceuticals worth $465 as of Q1 2026.
  • Rocket Pharmaceuticals was a new Parkside Financial Bank & Trust position in Q1 2026.
  • Rocket Pharmaceuticals made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #2576 holding.
  • Parkside Financial Bank & Trust first reported a position in Rocket Pharmaceuticals in Q1 2025 and has held it in 2 quarters since.
  • Parkside Financial Bank & Trust's Rocket Pharmaceuticals position peaked at $731 in Q1 2025.
  • 199 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.